SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-023860
Filing Date
2022-11-09
Accepted
2022-11-09 16:12:14
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgo-20221109.htm   iXBRL 8-K 61574
2 EX-99.1 imgo-ex99_1.htm EX-99.1 239081
3 GRAPHIC img230188249_0.jpg GRAPHIC 103913
  Complete submission text file 0000950170-22-023860.txt   584616

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20221109_lab.xml EX-101.LAB 18685
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20221109_pre.xml EX-101.PRE 11494
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20221109.xsd EX-101.SCH 2462
8 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20221109_htm.xml XML 4894
Mailing Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065
Business Address 303 TWIN DOLPHIN DRIVE 6TH FLOOR REDWOOD CITY CA 94065 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 221372716
SIC: 2834 Pharmaceutical Preparations